169 related articles for article (PubMed ID: 37630420)
1. Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.
Manoharan A; Oh JM; Benny F; Kumar S; Abdelgawad MA; Ghoneim MM; Shaker ME; El-Sherbiny M; Almohaimeed HM; Gahtori P; Kim H; Mathew B
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630420
[TBL] [Abstract][Full Text] [Related]
2. Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.
Singh AK; Kim SM; Oh JM; Abdelgawad MA; Ghoneim MM; Rangarajan TM; Kumar S; Sudevan ST; Trisciuzzi D; Nicolotti O; Kim H; Mathew B
Chem Biol Drug Des; 2023 Aug; 102(2):271-284. PubMed ID: 37011915
[TBL] [Abstract][Full Text] [Related]
3. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
4. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
[TBL] [Abstract][Full Text] [Related]
5. Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment.
Benny F; Oh JM; Kumar S; Abdelgawad MA; Ghoneim MM; Abdel-Bakky MS; Kukerti N; Jose J; Kim H; Mathew B
RSC Adv; 2023 Nov; 13(50):35240-35250. PubMed ID: 38053684
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
7. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease.
Mathew GE; Oh JM; Mohan K; Tengli A; Mathew B; Kim H
J Biomol Struct Dyn; 2021 Aug; 39(13):4786-4794. PubMed ID: 32588753
[TBL] [Abstract][Full Text] [Related]
8. Design of enamides as new selective monoamine oxidase-B inhibitors.
Kavully FS; Oh JM; Dev S; Kaipakasseri S; Palakkathondi A; Vengamthodi A; Abdul Azeez RF; Tondo AR; Nicolotti O; Kim H; Bijo Mathew
J Pharm Pharmacol; 2020 Jul; 72(7):916-926. PubMed ID: 32246471
[TBL] [Abstract][Full Text] [Related]
9. Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.
Nair AS; Oh JM; Koyiparambath VP; Kumar S; Sudevan ST; Soremekun O; Soliman ME; Khames A; Abdelgawad MA; Pappachen LK; Mathew B; Kim H
Molecules; 2021 May; 26(11):. PubMed ID: 34071665
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
Alagöz MA; Oh JM; Zenni YN; Özdemir Z; Abdelgawad MA; Naguib IA; Ghoneim MM; Gambacorta N; Nicolotti O; Kim H; Mathew B
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744926
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents.
Kumar B; Kumar M; Dwivedi AR; Kumar V
ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334
[TBL] [Abstract][Full Text] [Related]
12. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
Zarmouh NO; Eyunni SK; Soliman KF
BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
[TBL] [Abstract][Full Text] [Related]
13. Novel indanone derivatives as MAO B/H
Affini A; Hagenow S; Zivkovic A; Marco-Contelles J; Stark H
Eur J Med Chem; 2018 Mar; 148():487-497. PubMed ID: 29477889
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
Tripathi RK; Krishnamurthy S; Ayyannan SR
ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and human monoamine oxidase inhibitory activity of novel C2-, C3- and C4-substituted phthalonitriles.
Elzien Alamin Ali H; Ozalp L; Danış Ö; Odabaş Z
Bioorg Med Chem Lett; 2022 Oct; 74():128917. PubMed ID: 35926797
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
[TBL] [Abstract][Full Text] [Related]
17. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
Agrawal N; Mishra P
Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
[TBL] [Abstract][Full Text] [Related]
19. Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson's Disorder.
Kumar S; Oh JM; Abdelgawad MA; Abourehab MAS; Tengli AK; Singh AK; Ahmad I; Patel H; Mathew B; Kim H
ACS Omega; 2023 Feb; 8(7):6908-6917. PubMed ID: 36844523
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.
Çeçen M; Oh JM; Özdemir Z; Büyüktuncel SE; Uysal M; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 Nov; 25(22):. PubMed ID: 33212876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
